Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease

Platelets

Volumn 24, Issue 2, 2013, Pages 151-155

  Mazur, Piotr ^a   Frołow, Marzena ^a   Nizankowski, Rafał ^a   Sadowski, Jerzy ^a,b   Undas, Anetta ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Aspirin; CAD; Clopidogrel; PAD; Resistance; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THROMBOXANE B2;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG RESPONSE; FEMALE; HUMAN; MALE; MEDICAL HISTORY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; STENT; STENT THROMBOSIS; THROMBOCYTE AGGREGATION INHIBITION;

AGED; ANGIOPLASTY; ASPIRIN; BLOOD PLATELETS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 84873332277     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.676220     Document Type: Article

References (15)

1. Visonà A, Tonello D, Zalunardo B, Irsara S, Liessi G, Marigo L, Zotta L. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood Transfus 2009;7:18-23
2. Steg PG, Dorman SH, Amarenco P. Atherothrombosis and the role of antiplatelet therapy. J Thromb Haemost 2011;9: 325-332
3. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107:2908-2913 (Pubitemid 36736631)
4. Müller I, Besta F, Schulz C, Massberg S, Schö nig A, Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 2003;89:783-787 (Pubitemid 36603418)
5. Gurbel P, Tantry US, Shuldiner AR, Kereiakes DJ. Genotyping. One piece of the puzzle to personalize antiplatelet therapy. J Am Coll Cardiol 2010;56:112-116
6. Rajendran S, Parikh D, Shugman I, French JK, Juergens CP. High on treatment platelet reactivity and stent thrombosis. Heart Lung Circ 2011;20:525-531
7. Jeremias A, Gruberg L, Patel J, Connors G, Brown DL. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2010;105:1268-1271
8. Gajos G, Rostoff P, Undas A, Piwowarska W. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The OMEGA-PCI (OMEGA-3 fatty acids after PCI to modify responsiveness to dual antiplatelet therapy) study. J Am CollCardiol 2010;55: 1671-1678
9. Visonà A, Tonello D, Zalunardo B, Irsara S, Liessi G, Marigo L, Zotta L. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood Transfus 2009;7:18-23
10. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-Analysis. Am Heart J 2007;154:221-231 (Pubitemid 47069129)
11. Soejima H, Morimoto T, Saito Y, Ogawa H. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials. Thromb Haemost 2010;104:1085-1088
12. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339
13. Drouet L, Baldit Sollier C, Henry P. The basis of platelets: Platelets and atherothrombosis: An understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients. Drugs 2010;70:9-14
14. Linnemann B, Prochnow S, Mani H, Schwonberg J, Lindhoff-Last E. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-Term follow-up. Ann Hematol 2009;88:979-988
15. Kajiwara I, Soejima H, Miyamoto S, Ogawa H. Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina. Thromb Res 2011;128:547-551